GWMR
GSK icon

GC Wealth Management RIA’s GSK GSK Stock Holding History

GC Wealth Management RIA’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,763
Closed -$767K – 658
2025
Q3 		$767K Buy
17,763
+1,589
+10% +$62.1K 0.03% 416
2025
Q2 		$621K Buy
16,174
+136
+0.8% +$5.2K 0.05% 284
2025
Q1 		$621K Buy
16,038
+2,029
+14% +$74.3K 0.11% 158
2024
Q4 		$474K Buy
14,009
+353
+3% +$12.7K 0.08% 182
2024
Q3 		$558K Buy
13,656
+2,191
+19% +$89.6K 0.1% 180
2024
Q2 		$441K Buy
11,465
+847
+8% +$35.6K 0.09% 187
2024
Q1 		$455K Buy
10,618
+708
+7% +$29.2K 0.09% 177
2023
Q4 		$367K Buy
+9,910
New +$356K 0.17% 138

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GC Wealth Management RIA's GSK Position: Q4 2025 in Review

GC Wealth Management RIA sold out of GSK (GSK) in Q4 2025, closing a stake of 17,763 shares — an estimated $767K sold.

GC Wealth Management RIA first reported a position in GSK in Q4 2023 and held it in 8 quarters. The position peaked at $767K in Q3 2025. 998 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • GC Wealth Management RIA reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • GC Wealth Management RIA sold 17,763 GSK shares in Q4 2025, an estimated $767K.
  • GC Wealth Management RIA first reported a position in GSK in Q4 2023 and held it in 8 quarters.
  • GC Wealth Management RIA's GSK position peaked at $767K in Q3 2025.
  • 998 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on GC Wealth Management RIA's 13F filing for Q4 2025, filed 30 Jan 2026.